Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Boehringer Ingelheim
Baxter
Queensland Health
Deloitte
Farmers Insurance
Express Scripts
Harvard Business School
Daiichi Sankyo

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,841,252

« Back to Dashboard

Summary for Patent: 8,841,252
Title:Pharmaceutical formulation
Abstract: The invention relates to aqueous pharmaceutical formulations comprising human growth hormone, histidine, poloxamer, phenol, and mannitol.
Inventor(s): Bjorn; Soren (Lyngby, DK), Sorensen; Hans Holmegaard (Virum, DK), Langballe; Peter (Charlottenlund, DK), Larsen; Silke Moller (Charlottenlund, DK), Ebbehoj; Kristen (N.ae butted.rum, DK), Hansen; Birthe Lykkegaard (V.ae butted.rlose, DK)
Assignee: Novo Nordisk Health Care AG (Zurich, CH)
Application Number:12/575,886
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 8,841,252

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-008 Mar 1, 2010 BX RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-009 Mar 1, 2010 BX RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-010 Mar 1, 2010 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Novo Nordisk Inc NORDITROPIN FLEXPRO somatropin recombinant INJECTABLE;INJECTION 021148-011 Jan 23, 2015 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Novo Nordisk Inc NORDITROPIN NORDIFLEX somatropin recombinant INJECTABLE;INJECTION 021148-007 Mar 10, 2009 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,841,252

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0490/96Apr 24, 1996

International Patents Family Members for US Patent 8,841,252

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland 188222 ➤ Subscribe
Hungary 9902476 ➤ Subscribe
Hungary 229868 ➤ Subscribe
Israel 126463 ➤ Subscribe
Japan 2000508665 ➤ Subscribe
Japan 4176834 ➤ Subscribe
Japan 2008231124 ➤ Subscribe
South Korea 20000010630 ➤ Subscribe
Norway 984951 ➤ Subscribe
Norway 323360 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
McKinsey
Deloitte
Queensland Health
QuintilesIMS
Johnson and Johnson
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot